Literature DB >> 12439291

Apolipoprotein E polymorphism and acute ischemic stroke: a diffusion- and perfusion-weighted magnetic resonance imaging study.

Yawu Liu1, Mikko P Laakso, Jari O Karonen, Ritva L Vanninen, Juho Nuutinen, Seppo Soimakallio, Hannu J Aronen.   

Abstract

Diffusion- and perfusion-weighted magnetic resonance imaging (MRI) was used to study the putative effects of apolipoprotein E (ApoE) polymorphism in stroke. Thirty-one patients with acute stroke, comparative for age and gender were scanned, nine of whom were ApoE allele epsilon 4 carriers. Initially, less than 24 hours from the onset of stroke, the epsilon 4 carriers had significantly smaller volumes of hypoperfusion on relative cerebral blood volume map (P = 0.001), and smaller infarct volumes (P = 0.008) compared with the noncarriers. By day 8, this difference in the infarct volumes had disappeared, suggesting relatively enhanced infarct growth. On average, the total infarct volume increased 145% of the initial infarct volume in the epsilon 4 carriers, and 84% in the noncarriers. There were strong correlations between the imaging findings and clinical status initially and with the outcome 3 months after the stroke in the epsilon 4 noncarriers, but, with a single exception at acute phase, a lack thereof in the epsilon 4 carriers. These patterns were virtually similar in a subgroup of patients with middle cerebral artery stroke. These data support the hypothesis of increased general vulnerability of the brain in the epsilon 4 carriers. Thus, the effects of ApoE polymorphism should be accounted for when interpreting diffusion- and perfusion-weighted MRI studies, particularly if predicting lesion growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439291     DOI: 10.1097/01.WCB.0000033200.58646.B3

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  12 in total

Review 1.  Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis).

Authors:  Zoltán Szolnoki
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

2.  Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adults.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Tyler A Zink; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12-31       Impact factor: 2.035

Review 3.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

4.  Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  P D Schellinger; R N Bryan; L R Caplan; J A Detre; R R Edelman; C Jaigobin; C S Kidwell; J P Mohr; M Sloan; A G Sorensen; S Warach
Journal:  Neurology       Date:  2010-07-13       Impact factor: 9.910

Review 5.  Alzheimer's disease and cholesterol: the fat connection.

Authors:  Laura Canevari; John B Clark
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

Review 6.  Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage.

Authors:  N A Martínez-González; C L M Sudlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08-22       Impact factor: 10.154

Review 7.  Systematic review of CT and MR perfusion imaging for assessment of acute cerebrovascular disease.

Authors:  J M Provenzale; K Shah; U Patel; D C McCrory
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

Review 8.  Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer's disease.

Authors:  Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Meta-analysis of APOE ε2/ε3/ε4 polymorphism and cerebral infarction.

Authors:  Qian-you Wang; Wen-jing Wang; Lei Wu; Liang Liu; Li-zhu Han
Journal:  J Neural Transm (Vienna)       Date:  2013-04-10       Impact factor: 3.575

10.  The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.

Authors:  Heming Wu; Qingyan Huang; Zhikang Yu; Hailing Wu; Zhixiong Zhong
Journal:  Lipids Health Dis       Date:  2020-09-05       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.